No video

A Ticking Time Bomb: Tracing the Origin and Spread of SARS-CoV-2

  Рет қаралды 582

BPS Bioscience

BPS Bioscience

Күн бұрын

For years, virologists predicted that coronaviruses would jump from animals to humans, causing new diseases. Unfortunately, those fears have been realized and SARS-CoV-2 now spreads across the globe. Due to the COVID-19 pandemic, research on the origins and spread of coronaviruses is taking center stage. In this webinar from The Scientist, coronavirus experts will describe how SARS-CoV-2 came to infect humans. Linda Saif will give a historical overview of SARS spillovers from animals to humans, and Neville Sanjana will describe recent work on a SARS-CoV-2 spike protein variant that increases human infectivity.
Topics to be covered
- A historical overview of coronavirus spillovers from animals to humans
- The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types

Пікірлер
Cancer Immunotherapy: where will the future opportunities be?
1:09:11
BPS Bioscience
Рет қаралды 2,5 М.
Webinar - PROTACs and Their Application in Cancer Therapeutics
1:27:51
Happy birthday to you by Tsuriki Show
00:12
Tsuriki Show
Рет қаралды 12 МЛН
Prank vs Prank #shorts
00:28
Mr DegrEE
Рет қаралды 10 МЛН
Joker can't swim!#joker #shorts
00:46
Untitled Joker
Рет қаралды 40 МЛН
Penetrating Solid Tumors with CAR Immune Cells
1:21:37
BPS Bioscience
Рет қаралды 9 М.
Gerald S. Shadel  Talk title: The “Age” of Mitochondria
57:41
Salk Institute
Рет қаралды 18 М.
The Promise of CAR NK Cell Therapy
1:12:36
BPS Bioscience
Рет қаралды 4,1 М.
The Science and Practice of Happiness Across the Lifespan - Frank B. Roehr Memorial Lecture
1:25:25
University of California Television (UCTV)
Рет қаралды 57 М.
Robert Greene: A Process for Finding & Achieving Your Unique Purpose
3:11:18
Andrew Huberman
Рет қаралды 11 МЛН
Inside Innovation: Shirley Meng - The Global Race for Better Batteries
53:47
The Qualcomm Institute
Рет қаралды 12 М.
What is ChatGPT doing...and why does it work?
3:15:38
Wolfram
Рет қаралды 2,1 МЛН